New Anti-VEGF Drugs in Ophthalmology
- PMID: 32342814
- DOI: 10.2174/1389450121666200428101738
New Anti-VEGF Drugs in Ophthalmology
Abstract
This review focuses on 5 new anti-VEGF drugs in the advanced stage of clinical development (i.e., phase 3): conbercept, brolucizumab, port delivery system with ranibizumab, abicipar pegol and faricimab. Results of clinical trials and the advantages of each drug compared to the available molecules are discussed in detail.
Keywords: Anti-VEGF; abicipar pegol; brolucizumab; conbercept; faricimab; port delivery system; ranibizumab.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
